In this study, we chose to enrol older patients with NT-proBNP ≥ 125 pg/ml according to what has been recommended by the 2021 ESC Guidelines [8] for guiding HF diagnosis and the decision to perform an echocardiographic evaluation to objectify the presence of heart disease. The gene discussed is NPPB; the disease is hydrops fetalis.